Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Ordinary shares, par value $0.0001 per share
-
Shares outstanding
-
1,385,160,313
-
Number of holders
-
205
-
Total 13F shares, excl. options
-
48,964,204
-
Shares change
-
+171,494
-
Total reported value, excl. options
-
$6,027,968,489
-
Value change
-
-$8,363,206
-
Put/Call ratio
-
61%
-
Number of buys
-
112
-
Number of sells
-
94
-
Price
-
$123.11
Institutional Holders of BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) as of Q1 2020
As of 31 Mar 2020 BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) had 205 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 48,964,204 shares of stock of the company.
Largest 10 holders included BAKER BROS. ADVISORS LP, FMR LLC, Capital International Investors, HILLHOUSE CAPITAL ADVISORS, LTD., Temasek Holdings (Private) Ltd, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., PRIMECAP MANAGEMENT CO/CA/, CAPITAL INTERNATIONAL INC /CA/, and BOXER CAPITAL, LLC.
This table shows 205 institutional shareholders of the security as of 31 Mar 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.